Evidence map›Paper›PMID 26099452›Full record

ArticleScientific reports2015

Network-based survival-associated module biomarker and its crosstalk with cell death genes in ovarian cancer.

Nana Jin, Hao Wu, Zhengqiang Miao, Yan Huang, Yongfei Hu, Xiaoman Bi, Deng Wu, Kun Qian, Liqiang Wang, Changliang Wang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Developing a label propagation approach for cancer subtype classification problem.Turkish journal of biology = Turk biyoloji dergisi · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Classifying tumors by supervised network propagation.Bioinformatics (Oxford, England) · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Nana JinCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Hao WuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Zhengqiang MiaoCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Yan HuangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Yongfei HuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Xiaoman BiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Deng WuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Kun QianCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Liqiang WangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Changliang WangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Hongwei WangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Kongning LiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Xia LiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Dong WangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer remains a dismal disease with diagnosing in the late, metastatic stages, therefore, there is a growing realization of the critical need to develop effective biomarkers for understanding underlying mechanisms. Although existing evidences demonstrate the important role of the single genetic abnormality in pathogenesis, the perturbations of interactors in the complex network are often ignored. Moreover, ovarian cancer diagnosis and treatment still exist a large gap that need to be bridged. In this work, we adopted a network-based survival-associated approach to capture a 12-gene network module based on differential co-expression PPI network in the advanced-stage, high-grade ovarian serous cystadenocarcinoma. Then, regulatory genes (protein-coding genes and non-coding genes) direct interacting with the module were found to be significantly overlapped with cell death genes. More importantly, these overlapping genes tightly clustered together pointing to the module, deciphering the crosstalk between network-based survival-associated module and cell death in ovarian cancer.

Indexed as

Gene Regulatory NetworksBiomarkers, TumorCell DeathDatabases, GeneticFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMultivariate AnalysisNeoplasm GradingOvarian NeoplasmsProportional Hazards ModelsReproducibility of ResultsRisk FactorsTreatment OutcomeBiomarkers, Tumor

Identifiers

PMID26099452
PMCPMC4477367
OpenAlexW2411950200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.